Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Nov;49(11):920–925. doi: 10.1136/jcp.49.11.920

Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status.

K Collett 1, F Hartveit 1, R Skjaerven 1, B O Maehle 1
PMCID: PMC500833  PMID: 8944613

Abstract

AIMS: To consider the prognostic role of oestrogen receptor and progesterone receptor status in relation to the age at surgery, length of follow up and lymph node status. METHODS: The study population comprised 977 patients with histologically confirmed breast carcinoma, with a median follow up of nine years. The actuarial life table method was used to test for survival differences. The Cox proportional hazard model was used to test for interaction effects between each hormone receptor and age, lymph node status and length of follow up. As the analysis involved multiple subgroups, significance was set at the 1% level (p < 0.01). RESULTS: When the patients were subdivided into groups according to lymph node status and age, progesterone and oestrogen receptor status predicted prognosis in middle aged (46-60 years) patients with lymph node positive breast cancer. Their prognostic effect in this subgroup, however, was restricted to the first five years after surgery. Progesterone receptor status was the strongest predictor of outcome. CONCLUSION: The prognostic power of oestrogen and progesterone receptor status varies depending on age, lymph node status and length of follow up after surgery.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aamdal S., Børmer O., Jørgensen O., Høst H., Eliassen G., Kaalhus O., Pihl A. Estrogen receptors and long-term prognosis in breast cancer. Cancer. 1984 Jun 1;53(11):2525–2529. doi: 10.1002/1097-0142(19840601)53:11<2525::aid-cncr2820531126>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  2. Andry G., Suciu S., Pratola D., Sylvester R., Leclercq G., da Costa P. M., Legros N., Andry-t'Hooft M., Verhest A., Mattheiem W. Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer. Eur J Cancer Clin Oncol. 1989 Feb;25(2):319–329. doi: 10.1016/0277-5379(89)90025-4. [DOI] [PubMed] [Google Scholar]
  3. Badwe R. A., Gregory W. M., Chaudary M. A., Richards M. A., Bentley A. E., Rubens R. D., Fentiman I. S. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet. 1991 May 25;337(8752):1261–1264. doi: 10.1016/0140-6736(91)92927-t. [DOI] [PubMed] [Google Scholar]
  4. Clark G. M. Do we really need prognostic factors for breast cancer? Breast Cancer Res Treat. 1994;30(2):117–126. doi: 10.1007/BF00666054. [DOI] [PubMed] [Google Scholar]
  5. Clark G. M., Wenger C. R., Beardslee S., Owens M. A., Pounds G., Oldaker T., Vendely P., Pandian M. R., Harrington D., McGuire W. L. How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer. Cancer. 1993 Mar 15;71(6 Suppl):2157–2162. doi: 10.1002/1097-0142(19930315)71:6+<2157::aid-cncr2820711606>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  6. Collett K., Skjaerven R., Thorsen T., Hartveit F., Maehle B. O. The prognostic role of progesterone receptor status and age in relation to axillary node status in breast cancer patients. Eur J Cancer Clin Oncol. 1989 Jun;25(6):959–964. doi: 10.1016/0277-5379(89)90154-5. [DOI] [PubMed] [Google Scholar]
  7. Davidson N. E., Abeloff M. D. Adjuvant therapy of breast cancer. World J Surg. 1994 Jan-Feb;18(1):112–116. doi: 10.1007/BF00348200. [DOI] [PubMed] [Google Scholar]
  8. Galea M. H., Blamey R. W., Elston C. E., Ellis I. O. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat. 1992;22(3):207–219. doi: 10.1007/BF01840834. [DOI] [PubMed] [Google Scholar]
  9. Glick J. H., Gelber R. D., Goldhirsch A., Senn H. J. Adjuvant therapy of primary breast cancer: closing summary. Recent Results Cancer Res. 1993;127:289–300. doi: 10.1007/978-3-642-84745-5_38. [DOI] [PubMed] [Google Scholar]
  10. Howat J. M., Harris M., Swindell R., Barnes D. M. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer. 1985 Feb;51(2):263–270. doi: 10.1038/bjc.1985.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Klijn J. G., Look M. P., Portengen H., Alexieva-Figusch J., van Putten W. L., Foekens J. A. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study. Breast Cancer Res Treat. 1994 Jan;29(1):73–83. doi: 10.1007/BF00666183. [DOI] [PubMed] [Google Scholar]
  12. Logan L. A., Cripps M. C., Hirte W. E., Rapp E. F. The estrogen receptor test: a prognostic tool in primary breast cancer. Can J Surg. 1982 Sep;25(5):581–584. [PubMed] [Google Scholar]
  13. Mason B. H., Holdaway I. M., Stewart A. W., Neave L. M., Kay R. G. Season of initial discovery of tumour as an independent variable predicting survival in breast cancer. Br J Cancer. 1990 Jan;61(1):137–141. doi: 10.1038/bjc.1990.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mathiesen O., Bonderup O., Carl J., Panduro J., Pedersen K. O. The prognostic value of estrogen and progesterone receptors in female breast cancer. A single center study. Acta Oncol. 1991;30(6):691–695. doi: 10.3109/02841869109092441. [DOI] [PubMed] [Google Scholar]
  15. McGuire W. L., Clark G. M., Dressler L. G., Owens M. A. Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr. 1986;(1):19–23. [PubMed] [Google Scholar]
  16. Meyer J. S., Province M. A. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Cancer. 1994 Oct 15;74(8):2287–2299. doi: 10.1002/1097-0142(19941015)74:8<2287::aid-cncr2820740813>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  17. Molino A., Turazza M., Bonetti A., Biondani P., Griso C., Adami L., Corgnati A., Nortilli R., Pollini G. P., Modena S. Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. Oncology. 1992;49(2):82–88. doi: 10.1159/000227017. [DOI] [PubMed] [Google Scholar]
  18. Nordén T., Lindgren A., Bergström R., Holmberg L. Defining a high mortality risk group among women with primary breast cancer. Br J Cancer. 1994 Mar;69(3):520–524. doi: 10.1038/bjc.1994.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Oestrogen receptors and survival in early breast cancer. Br Med J (Clin Res Ed) 1982 Feb 20;284(6315):597–598. doi: 10.1136/bmj.284.6315.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pichon M. F., Pallud C., Brunet M., Milgrom E. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res. 1980 Sep;40(9):3357–3360. [PubMed] [Google Scholar]
  21. Pichon M. F., Pallud C., Hacene K., Milgrom E. Prognostic value of progesterone receptor after long-term follow-up in primary breast cancer. Eur J Cancer. 1992;28A(10):1676–1680. doi: 10.1016/0959-8049(92)90067-c. [DOI] [PubMed] [Google Scholar]
  22. Pinder S. E., Ellis I. O., Elston C. W. Prognostic factors in primary breast carcinoma. J Clin Pathol. 1995 Nov;48(11):981–983. doi: 10.1136/jcp.48.11.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Raemaekers J. M., Beex L. V., Koenders A. J., Pieters G. F., Smals A. G., Benraad T. J., Kloppenborg P. W. Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Breast Cancer Res Treat. 1985;6(2):123–130. doi: 10.1007/BF02235743. [DOI] [PubMed] [Google Scholar]
  24. Remvikos Y., Magdelenat H., Dutrillaux B. Genetic evolution of breast cancers. III: Age-dependent variations in the correlations between biological indicators of prognosis. Breast Cancer Res Treat. 1995 Apr;34(1):25–33. doi: 10.1007/BF00666488. [DOI] [PubMed] [Google Scholar]
  25. Shek L. L., Godolphin W. Survival with breast cancer: the importance of estrogen receptor quantity. Eur J Cancer Clin Oncol. 1989 Feb;25(2):243–250. doi: 10.1016/0277-5379(89)90015-1. [DOI] [PubMed] [Google Scholar]
  26. Spyratos F., Hacene K., Tubiana-Hulin M., Pallud C., Brunet M. Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patients. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1233–1240. doi: 10.1016/0277-5379(89)90420-3. [DOI] [PubMed] [Google Scholar]
  27. Thorsen T. Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: relation to oestradiol and progesterone cytosol receptors. J Steroid Biochem. 1979 Jun;10(6):661–668. [PubMed] [Google Scholar]
  28. Winstanley J., Cooke T., George W. D., Murray G., Holt S., Croton R., Griffiths K., Nicholson R. The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer. 1991 Jul;64(1):99–101. doi: 10.1038/bjc.1991.249. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES